toprol-xl metoprolol succinate 23.75mg controlled release tablet blister pack
astrazeneca pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: silicon dioxide; ethylcellulose; hyprolose; microcrystalline cellulose; sodium stearylfumarate; synthetic paraffin; macrogol 6000; hypromellose; titanium dioxide - stable, chronic heart failure as an adjunct to other heart failure therapy.
tobeta-xl metoprolol succinate 23.75 mg modified release tablet bottle pack
pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; ethylcellulose; triethyl citrate; silicified microcrystalline cellulose; methacrylic acid copolymer; sodium stearylfumarate; macrogol 6000; povidone; purified talc; croscarmellose sodium; silicon dioxide; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.
topreloc-xl metoprolol succinate 23.75 mg modified release tablet blister pack
pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; sodium stearylfumarate; silicon dioxide; triethyl citrate; microcrystalline cellulose; purified talc; methacrylic acid copolymer; croscarmellose sodium; povidone; silicified microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.
topreloc-xl metoprolol succinate 23.75 mg modified release tablet bottle
pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: triethyl citrate; macrogol 6000; croscarmellose sodium; povidone; sodium stearylfumarate; purified talc; silicon dioxide; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.
tobeta-xl metoprolol succinate 23.75 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: purified talc; macrogol 6000; microcrystalline cellulose; povidone; silicon dioxide; triethyl citrate; sodium stearylfumarate; croscarmellose sodium; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.
myloc cr
viatris limited - metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base; ; - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension
metoprolol retard viatris 23.75 mg tabl. prol.-rel.
viatris gx bv-srl - metoprolol succinate 23,75 mg - eq. metoprolol tartrate 25 mg - prolonged-release tablet - 23,75 mg - metoprolol succinate 23.75 mg - metoprolol
selozok 25 23,75 mg tabl. prol.-rel.
recordati ireland ltd. - metoprolol succinate 23,75 mg - prolonged-release tablet - 23,75 mg - metoprolol succinate 23.75 mg - metoprolol
nicorette invisipatch 15mg/16hours 23.6 mg
مستودع أدوية العمد - al-amad drug store - nicotine 23.6 mg - 23.6 mg
23.4% sodium chloride injection usp solution
baxter corporation - sodium chloride - solution - 23.4% - sodium chloride 23.4% - replacement preparations